These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101 [TBL] [Abstract][Full Text] [Related]
32. [Adverse events following immunization reported with COVID-19 vaccines in Burkina Faso: Analysis of spontaneous reports]. Sawadogo R; Ouoba J; Ilboudo D; Tchoumbi E; Lankoandé-Haro S; Fofana S; Sombié I; Samadoulougou S; Kirakoya-Samadoulougou F Sante Publique; 2024 Feb; 35(6):149-159. PubMed ID: 38388395 [TBL] [Abstract][Full Text] [Related]
33. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Wattigney WA; Mootrey GT; Braun MM; Chen RT Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733 [TBL] [Abstract][Full Text] [Related]
34. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. Bines JE; Patel M; Parashar U J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611 [TBL] [Abstract][Full Text] [Related]
35. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194 [TBL] [Abstract][Full Text] [Related]
36. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS). Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546 [TBL] [Abstract][Full Text] [Related]
37. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. Escolano S; Hill C; Tubert-Bitter P Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460 [TBL] [Abstract][Full Text] [Related]
38. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013. Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510 [TBL] [Abstract][Full Text] [Related]
39. Signals and trends of Guillain-Barré syndrome after the introduction of live-attenuated vaccines for influenza in the US and South Korean adverse event reporting systems. Lee H; Kim HJ; Choe YJ; Shin JY Vaccine; 2020 Jul; 38(34):5464-5473. PubMed ID: 32600907 [TBL] [Abstract][Full Text] [Related]
40. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Cortese MM; Parashar UD; MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]